Rankings
▼
Calendar
LIVN Q1 2022 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena
LIVN
LivaNova PLC
$3B
Q1 2022 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$240M
-3.0% YoY
Gross Profit
$168M
70.1% margin
Operating Income
$10M
4.0% margin
Net Income
$3M
1.2% margin
EPS (Diluted)
$0.06
QoQ Revenue Growth
-11.1%
Cash Flow
Operating Cash Flow
$26M
Free Cash Flow
$21M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$2.4B
Total Liabilities
$1.1B
Stockholders' Equity
$1.3B
Cash & Equivalents
$442M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$240M
$248M
-3.0%
Gross Profit
$168M
$163M
+3.1%
Operating Income
$10M
-$6M
+266.8%
Net Income
$3M
-$31M
+109.7%
Revenue Segments
Cardiopulmonary Segment
$117M
49%
Neuromodulation Segment
$110M
46%
Advanced Circulatory Support Segment
$12M
5%
Geographic Segments
UNITED STATES
$136M
57%
Locations Excluding The United States And Europe
$59M
24%
Europe
$45M
19%
← FY 2022
All Quarters
Q2 2022 →